National Institute for Health Research (NIHR) | February 2019 |People with chronic obstructive pulmonary disease exacerbations prefer early discharge, then treatment at home
A randomised controlled trial (RCT) aimed to see if treating people at home was effective and cheaper for those at low risk of dying from an exacerbation of COPD according to the DECAF clinical prediction tool. The study followed 120 people admitted to three hospitals in England with a COPD exacerbation who had a DECAF score of 0 or 1. This indicated a low risk of dying; about half of people fall into this category. People were assigned to either stay in hospital or have “hospital at home.”
This study supports the current move towards assisted discharge schemes supported by hospital at home for selected people with exacerbations of COPD. The evidence adds data, and the authors note that those cared for at home prefer this option. The DECAF score seems a practical choice for assessing risk (Source: NIHR).
Read the full NIHR Signal